))
Tail Risks 2021
Manage episode 403072083 series 3234084
Conteúdo fornecido por OCBC Treasury Research and Strategy - Podcast, OCBC Treasury Research, and Strategy - Podcast. Todo o conteúdo do podcast, incluindo episódios, gráficos e descrições de podcast, é carregado e fornecido diretamente por OCBC Treasury Research and Strategy - Podcast, OCBC Treasury Research, and Strategy - Podcast ou por seu parceiro de plataforma de podcast. Se você acredita que alguém está usando seu trabalho protegido por direitos autorais sem sua permissão, siga o processo descrito aqui https://pt.player.fm/legal.
Vaccine haves and have-nots. Stepping into 2021, let’s take a look at the potential tail risks presented by vaccine development. On the positive end, if we can find more “sweet spot” vaccines that are not just effective but relatively easy to roll out in many developing countries, we would see a great upsurge in consumer and business confidence. On the flip side, if such vaccines are not readily available, a sharp dichotomy between the (vaccinated) rich world and (unvaccinated) others could have tremendous negative implications on market sentiment towards emerging markets in 2021.
…
continue reading
136 episódios
Compartilhar
